Response to 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Gremese et al

Affiliations

¹ Section of Gastroenterology, Department of Medicine, The University of Chicago Medicine, Chicago, Illinois, USA.
² Division of Gastroenterology, Hepatology and Motility, Department of Internal Medicine, University of Kansas, Kansas City, Kansas, USA.
³ Section of Gastroenterology, Department of Medicine, The University of Chicago Medicine, Chicago, Illinois, USA asakurab@medicine.bsd.uchicago.edu.

Comment

Shintaro Akiyama et al. Ann Rheum Dis. 2023 Jan.

. 2023 Jan;82(1):e6.

doi: 10.1136/annrheumdis-2020-219337. Epub 2020 Nov 3.

¹ Section of Gastroenterology, Department of Medicine, The University of Chicago Medicine, Chicago, Illinois, USA.
² Division of Gastroenterology, Hepatology and Motility, Department of Internal Medicine, University of Kansas, Kansas City, Kansas, USA.
³ Section of Gastroenterology, Department of Medicine, The University of Chicago Medicine, Chicago, Illinois, USA asakurab@medicine.bsd.uchicago.edu.

No abstract available

Keywords: autoimmune diseases; biological therapy; glucocorticoids.

Conflict of interest statement

Competing interests: None declared.

Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis.
Akiyama S, Hamdeh S, Micic D, Sakuraba A. Akiyama S, et al. Ann Rheum Dis. 2021 Mar;80(3):384-391. doi: 10.1136/annrheumdis-2020-218946. Epub 2020 Oct 13. Ann Rheum Dis. 2021. PMID: 33051220
Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'.
Gremese E, Brondani G, Apollonio L, Ferraccioli G. Gremese E, et al. Ann Rheum Dis. 2023 Jan;82(1):e5. doi: 10.1136/annrheumdis-2020-219309. Epub 2020 Nov 3. Ann Rheum Dis. 2023. PMID: 33144307 No abstract available.